Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • All Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

Warning: foreach() argument must be of type array|object, null given in /var/www/wordpress/wp-content/themes/awaken-child/single-newsletter.php on line 54

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Treatment
  4. /
  5. Immune Globulin Subcutaneous (Human),...

Immune Globulin Subcutaneous (Human), 20% Liquid

February 8, 2015[email protected]
Immune Globulin Subcutaneous (Human), 20% Liquid
Trade Name Hizentra
Orphan Indication Chronic inflammatory demyelinating polyneuropathy
USA Market Approval USA
USA Designation Date 2014-08-18 00:00:00
Sponsor CSL Behring;P. O. Box 61501, 1020 First Avenue;King of Prussia, Pennsylvania, 19406

Free Newsletter

Related

  • Immune globulin infusion 10% (human) with recombinant human hyaluronid
  • Recombinant multimerized human IgG1 Fc
  • Fingolimod
  • Immune Globulin (Human)
More Treatment
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2023 CheckOrphan.
    Developed by: Gonza.io logo Powered by: Cloudscale logo